BACKGROUND High CHA 2 DS 2-VASc scores in atrial fibrillation (AF) patients are generally associated with increased risks of stroke and dementia. At lower CHA 2 DS 2-VASc scores, there remains an unquantifiable cranial injury risk, necessitating an improved risk assessment method within these lower-risk groups. OBJECTIVE The purpose of this study was to determine whether sex-specific Intermountain Mortality Risk Scores (IMRS), a dynamic measures of systemic health that comprises commonly performed blood tests, can stratify dementia risk overall and among CHA 2 DS 2-VASc score strata in AF patients. METHODS Female (n 5 34,083) and male (n 5 39,998) AF patients with no history of dementia were studied. CHA 2 DS 2-VASc scores were assessed at the time of AF diagnosis and were stratified into scores of 0-1, 2, and 3. Within each CHA 2 DS 2-VASc score stratum, patients were further stratified by IMRS categories of low, moderate, and high. Multivariable Cox hazard regression was used to determine dementia risk. RESULTS High-risk IMRS patients were generally older and had higher rates of hypertension, diabetes, heart failure, and prior stroke. Higher CHA 2 DS 2-VASc score strata (3 vs 1: women, hazard ratio [HR] 7.77, 95% confidence interval [CI] 5.94-10.17, P , .001; men: HR 4.75, 95% CI 4.15-5.44, P , .001) and IMRS categories (high vs low: women, HR 3.09, 95% CI 2.71-3.51, P , .001; men, HR 2.70, 95% CI 2.39-3.06, P , .001) were predictive of dementia. When stratified by CHA 2 DS 2-VASc scores, IMRS further identified risk in each stratum. CONCLUSION Both CHA 2 DS 2-VASc scores and IMRS were independently associated with dementia incidence among AF patients. IMRS further stratified dementia risk among CHA 2 DS 2-VASc score strata, particularly among those with lower CHA 2 DS 2-VASc scores.